Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer
Ongoing recruitment for a study evaluating immune responses to anti-HER2 therapies in patients with HER2-positive breast cancer across stage…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Real World Study of Biosimilar Trastuzumab in Her2 Positive Breast Cancer
Real-world study evaluating a biosimilar trastuzumab for breast cancer; the trial status is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Prehabilitation of Breast Cancer-Related Lymphedema [NA]
Clinical trial update indicating the study on prehabilitation for breast cancer-related arm lymphedema has completed, with mentions of quali…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS) [NA]
This clinical trial update describes a telemedicine and mobile health symptom management intervention for advanced cancer patients (FOCUS), …
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: First-Line Sacituzumab Govitecan in Advanced Untreated Triple-Negative Breast Cancer Patients. [Phase 2]
A Phase 2 trial evaluating sacituzumab govitecan as first-line therapy in adults with advanced untreated triple-negative breast cancer; the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Comparison of the Efficacy of Cryotherapy Combined With Compression in Preventing Neuropathy [NA]
A clinical trial evaluating whether cryotherapy combined with compression can prevent neuropathy in patients with non-metastatic breast canc…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial update indicates Patritumab Deruxtecan (U3-1402) is being studied in unresectable locally advanced or metastatic br…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: A Study of A166 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update for A166 in patients with HER2-positive unresectable or metastatic breast cancer. The study is currently recru…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Study Assessing QBS72S For Treating Brain Metastases [Phase 2]
Stanford University is conducting a Phase 2 trial of QBS72S for brain metastases. The study lists brain metastases, breast cancer, lung canc…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: An Exploratory Study of Pertuzumab and Trastuzumab in Combination With Palbociclib and Exemestane as Neoadjuvant Therapy for Triple-Positive Breast Cancer [Phase 2]
Phase 2 exploratory study evaluating Pertuzumab and Trastuzumab with Palbociclib and Exemestane as neoadjuvant therapy for triple-positive b…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer [Phase 2]
A Phase 2 trial of pembrolizumab in combination with mifepristone for advanced HER2-negative breast cancer has been terminated.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: An Exploratory Study on Individualized Neoadjuvant Treatment Regimens for Early HR+/HER2+ Breast Cancer [Phase 2]
A Phase 2 exploratory trial evaluating individualized neoadjuvant treatment regimens for early HR+/HER2+ breast cancer, currently not yet re…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors [NA]
This clinical trial is evaluating metabolic responses to broccoli microgreens in obese breast cancer survivors and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: BRAVE-HEART: Breast Cancer Radiotherapy Using Active Breathing Coordinator to aVoid Exposure of HEART
This clinical trial update describes the BRAVE-HEART study, which uses an Active Breathing Coordinator during breast cancer radiotherapy to …
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases [Phase 1, Phase 2]
A Phase 1/2 clinical trial is testing stereotactic radiosurgery with olaparib followed by durvalumab and physician's choice systemic therapy…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) Study
The IMAGINE study is exploring whether MRI background parenchymal enhancement is a risk factor for breast cancer, and the trial is currently…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: ExBRAC- Expressive Writing in Breast Cancer [NA]
This document provides an update on the ExBRAC trial evaluating expressive writing in individuals with breast cancer, with the study listed …
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Sensitivity of Organoids to Predict Treatment Outcome in Breast Cancer Metastases
This clinical trial update describes a study investigating whether patient-derived organoids from breast cancer metastases can predict treat…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy [Phase 2]
This update describes a Phase 2 clinical trial evaluating the safety of neoadjuvant palbociclib in combination with endocrine therapy for br…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating ribociclib with adjuvant endocrine therapy for ER-positive breast cancer is active but not recruiting at…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.
A recruiting clinical trial investigating whether selenoproteins can serve as prognostic biomarkers and therapeutic targets in breast cancer…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas [Phase 2]
A Phase 2 clinical trial update describes a program for in-home cancer treatment with remote expert support, currently recruiting for patien…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Prospective Study on ICG Lymphoscintigraphy Changes Before and After Radiotherapy in Breast Cancer Patients
A prospective study is evaluating changes in indocyanine green (ICG) lymphoscintigraphy in breast cancer patients before and after radiother…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope [NA]
This trial update describes using methylene blue with a radiopharmaceutical isotope to identify sentinel lymph nodes in breast cancer.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Safety and Feasibility of IRE for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory Study [NA]
Prospective, open-label, single-arm exploratory trial investigating the safety and feasibility of irreversible electroporation (IRE) for ear…